Articles

Multicentric Castleman’s Disease Overview and Update on Its Pathogenesis

ASH 2014 - Castleman's Disease, ASH Highlights

Conference Correspondent

Foundation Medicine on a Molecular Level

Foundation Medicine on a Molecular Level

By Gary Palmer, MD

Personalized Medicine

Dr. Gary Palmer explains how Foundation Medicine is working to improve cancer therapies and personalized medicine on a molecular level.

Personalizing Cancer Treatment Based on a Unique Genetic Profile

By Gary Palmer, MD

Personalized Medicine

Gary Palmer, MD, explains how research is ahead of the physician and patient and the need to educate the physician and patient on all the information about DNA and what drives the cancer.

Is Research Translating to Meaningful Treatment to Patients?

Is Research Translating to Meaningful Treatment to Patients?

By Gary Palmer, MD

Personalized Medicine

Dr. Palmer describes how the direct relationship between treatment directed to change in the DNA actually affects the outcome of patients.

How to Better Establish Clinical Utility for Tests in Personalized Medicine

How to Better Establish Clinical Utility for Tests in Personalized Medicine

By Gary Palmer, MD

Personalized Medicine

Dr. Gary Palmer discusses the different profile of tumors and how to make findings as general as possible to better treat the patient.

Value-Based Concerns for Oncologists in the US

Value-Based Concerns for Oncologists in the US

By Gary Palmer, MD

Dr. Palmer talks about healthcare cost and the affect it has on an oncologist.

Oncologists and Cost Issues

Oncologists and Cost Issues

By Michael Kolodziej, MD

Dr. Palmer touches base on the importance of oncologists and consideration of cost issues, and gives a sense of how this impacts the healthcare system.

Foundation Medicine and Other Categories

Foundation Medicine and Other Categories

By Gary Palmer, MD

Practice Management, Value Peer-spectives

Gary Palmer, MD, speaks about all the applications of Foundation Medicine and its value in diseases other than cancer.

Patients and Treatment Discussions

Patients and Treatment Discussions

By Gary Palmer, MD

Personalized Medicine

Dr. Gary Palmer explains the importance of patients having choices and the need to be involved in all discussions on treatment options.

CLEOPATRA: Record-Breaking Survival in HER2 Metastatic Breast Cancer by Adding Pertuzumab

By Phoebe Starr

ESMO 2014 Highlights, ESMO

October 2014, Vol 5 , No 8

Madrid, Spain—Final results from the CLEOPATRA (Clinical Evaluation of Pertuzumab and Trastuzumab) trial show that dual HER2 blockade with the combination of pertuzumab and trastuzumab plus chemotherapy extended overall survival (OS) by almost 16 months compared with trastuzumab plus chemotherapy alone in patients with HER2-positive metastatic breast cancer.

Page 210 of 330